Endoscopic treatment of reflux: Management pros and cons

Current Opinion in Urology

Volumn 16, Issue 4, 2006, Pages 299-304

  Lorenzo, Armando J ^a   Khoury, Antoine E ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Advantages; Disadvantages; Endoscopic treatment; Vesicoureteral reflux

Indexed keywords

DEXTRANOMER; HYALURONIC ACID;

CHILD UROLOGY; CLINICAL PRACTICE; COMPARATIVE STUDY; ENDOSCOPIC THERAPY; HUMAN; IMAGING; KIDNEY SCAR; LONG TERM CARE; MEDICAL RESEARCH; MORBIDITY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SAFETY; SURGICAL RISK; TREATMENT OUTCOME; VESICOURETERAL REFLUX;

ENDOSCOPY; HUMANS; TIME FACTORS; UROLOGIC SURGICAL PROCEDURES; VESICO-URETERAL REFLUX;

EID: 33745205089     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mou.0000232054.12461.5f     Document Type: Review

References (77)

1. O'Donnell B. Reflections on reflux. J Urol 2004; 172:1635-1636.
2. Sargent MA. What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol 2000; 30:587-593.
3. Wheeler DM, Vimalachandra D, Hodson EM, et al. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev 2004; (3):CD001532.
4. Elder JS, Peters CA, Arant BS Jr, et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol 1997; 157:1846-1851.
5. Smellie JM, Barratt TM, Chantier C, et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet 2001; 357:1329-1333.
6. Matouschek E. Treatment of vesicorenal reflux by transurethral teflon-injection (author's transl). Urologe A 1981; 20:263-264.
7. Stenberg A, Hensle TW, Lackgren G. Vesicoureteral reflux: a new treatment algorithm. Curr Urol Rep 2002; 3:107-114.
8. Arant BS Jr. Medical management of mild and moderate Vesicoureteral reflux: followup studies of infants and young children. A preliminary report of the Southwest Pediatric Nephrology Study Group. J Urol 1992; 148:1683-1687.
9. Duckett JW. Vesicoureteral reflux: a 'conservative' analysis. Am J Kidney Dis 1983; 3:139-144.
10. Edwards D, Normand IC, Prescod N, et al. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. Br Med J 1977; 2:285-288.
11. McLorie GA, McKenna PH, Jumper BM, et al. High grade Vesicoureteral reflux: analysis of observational therapy. J Urol 1990; 144:537-540 [discussion 545].
12. Wennerstrom M, Hansson S, Jodal U, et al. Disappearance of Vesicoureteral reflux in children. Arch Pediatr Adolesc Med 1998; 152:879-883.
13. Connolly LP, Treves ST, Zurakowski D, et al. Natural history of Vesicoureteral reflux in siblings. J Urol 1996; 156:1805-1807.
14. Farhat W, McLorie G, Geary D, et al. The natural history of neonatal vesicoureteral reflux associated with antenatal hydronephrosis. J Urol 2000; 164:1057-1060.
15. Guarino N, Casamassima MG, Tadini B, et al. Natural history of vesicoureteral reflux associated with kidney anomalies. Urology 2005; 65:1208-1211. Presents data regarding reflux resolution in patients with multicystic dysplastic kidney, renal agenesis, and renal ectopia.
16. Upadhyay J, McLorie GA, Bolduc S, et al. Natural history of neonatal reflux associated with prenatal hydronephrosis: long-term results of a prospective study. J Urol 2003; 169:1837-1841 [discussion 1841, author reply 1841].
17. Herndon CD, McKenna PH, Kolon TF, et al. A multicenter outcomes analysis of patients with neonatal reflux presenting with prenatal hydronephrosis. J Urol 1999; 162:1203-1208.
18. Al-Sayyad AJ, Pike JG, Leonard MP. Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux? J Urol 2005; 174:1587-1589 [discussion 1589]. Retrospective outcome analysis of stopping prophylactic antibiotics in children with persistent VUR. Adds to the limited number of studies on this topic.
19. Cooper CS, Chung BI, Kirsch AJ, et al. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J Urol 2000; 163:269-272 [discussion 272-273].
20. Thompson RH, Chen JJ, Pugach J, et al. Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. J Urol 2001; 166:1465-1469.
21. Chen HW, Lin GJ, Lai CH, et al. Minimally invasive extravesical ureteral reimplantation for vesicoureteral reflux. J Urol 2002; 167:1821-1823.
22. Marotte JB, Smith DP. Extravesical ureteral reimplantations for the correction of primary reflux can be done as outpatient procedures. J Urol 2001; 165:2228-2231.
23. Putman S, Wicher C, Wayment R, et al. Unilateral extravesical ureteral reimplantation in children performed on an outpatient basis. J Urol 2005; 174:1987-1989 [discussion 1989-1990]. Interesting article that challenges the perceived longer hospital stay in patients who undergo open ureteral reimplantation.
24. Elder JS, Diaz M, Caldamone AA, et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 2006; 175:716-722. Landmark meta-analysis on reflux resolution and urinary tract infections in patients treated with different injectable agents.
25. Barrieras D, Lapointe S, Reddy PP, et al. Are postoperative studies justified after extravescial ureteral reimplantation? J Urol 2000; 164:1064-1066.
26. Bisignani G, Decter RM. Voiding cystourethrography after uncomplicated ureteral reimplantation in children: is it necessary? J Urol 1997; 158:1229-1231.
27. Lavine MA, Siddiq FM, Cahn DJ, et al. Vesicoureteral reflux after ureteroneo-cystostomy: indications for postoperative voiding cystography. Tech Urol 2001; 7:50-54.
28. Chertin B, De Caluwe D, Puri P. Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene. J Urol 2003; 169:1847-1849 [discussion 1849].
29. Kirsch AJ, Perez-Brayfield M, Smith EA, et al. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 2004; 171:2413-2416.
30. Kirsch AJ, Perez-Brayfield MR, Scherz HC. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. J Urol 2003; 170:211-215.
31. Perez-Brayfield M, Kirsch AJ, Hensle TW, et al. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux. J Urol 2004; 172:1614-1616.
32. Diamond DA, Caldamone AA, Bauer SB, et al. Mechanisms of failure of endoscopic treatment of vesicoureteral reflux based on endoscopic anatomy. J Urol 2003; 170:1556-1558 [discussion 1559].
33. Elmore JM, Scherz HC, Kirsch AJ. Dextranomer/hyaluronic acid for vesicoureteral reflux: success rates after initial treatment failure. J Urol 2006; 175: 712-715. Single-center data on the success rate for patients who have failed one previous subureteric injection.
34. Lackgren G, Wahlin N, Skoldenberg E, et al. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2001; 166:1887-1892.
35. Capozza N, Lais A, Nappo S, et al. The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience. J Urol 2004; 172:1626-1628 [discussion 1629].
36. Burno DK, Glazier DB, Zaontz MR. Lessons learned about contralateral reflux after unilateral extravesical ureteral advancement in children. J Urol 1998; 160:995-997 [discussion 1038].
37. Diamond DA, Rabinowitz R, Hoenig D, et al. The mechanism of new onset contralateral reflux following unilateral ureteroneocystostomy. J Urol 1996; 156:665-667.
38. Kumar R, Puri P. Newly diagnosed contralateral reflux after successful unilateral endoscopic correction: is it due to the pop-off mechanism? J Urol 1997; 158:1213-1215.
39. Sparr KE, Balcom AH, Mesrobian HG. Incidence and natural history of contralateral vesicoureteral reflux in patients presenting with unilateral disease. J Urol 1998; 160:1023-1025.
40. Snodgrass WT. Obstruction of a dysmorphic ureter following dextranomer/ hyaluronic acid copolymer. J Urol 2004; 171:395-396.
41. Olbing H, Smellie JM, Jodal U, et al. New renal scars in children with severe VUR: a 10-year study of randomized treatment. Pediatr Nephrol 2003; 18:1128-1131.
42. Smellie JM, Jodal U, Lax H, et al. Outcome at 10 years of severe vesicoureteric reflux managed medically: report of the International Reflux Study in Children. J Pediatr 2001; 139:656-663.
43. Austenfeld MS, Snow BW. Complications of pregnancy in women after reimplantation for vesicoureteral reflux. J Urol 1988; 140:1103-1106.
44. Bukowski TP, Betrus GG, Aquilina JW, et al. Urinary tract infections and pregnancy in women who underwent antireflux surgery in childhood. J Urol 1998; 159:1286-1289.
45. Cooper A, Atwell J. A long-term follow-up of surgically treated vesicoureteric reflux in girls. J Pediatr Surg 1993; 28:1034-1036.
46. Mansfield JT, Snow BW, Cartwright PC, et al. Complications of pregnancy in women after childhood reimplantation for vesicoureteral reflux: an update with 25 years of followup. J Urol 1995; 154:787-790.
47. Mor Y, Leibovitch I, Zalts R, et al. Analysis of the long-term outcome of surgically corrected vesico-ureteric reflux. BJU Int 2003; 92:97-100.
48. Smellie JM, Prescod NP, Shaw PJ, et al. Childhood reflux and urinary infection: a follow-up of 10-41 years in 226 adults. Pediatr Nephrol 1998; 12:727-736.
49. Grossklaus DJ, Pope JC, Adams MC, et al. Is postoperative cystography necessary after ureteral reimplantation? Urology 2001; 58:1041-1045.
50. Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol 1998; 160:1019-1022.
51. Upadhyay J, Bolduc S, Bagli DJ, et al. Use of the dysfunctional voiding symptom score to predict resolution of vesicoureteral reflux in children with voiding dysfunction. J Urol 2003; 169:1842-1846 [discussion 1846, author reply 1846].
52. Capozza N, Lais A, Matarazzo E, et al. Influence of voiding dysfunction on the outcome of endoscopic treatment for vesicoureteral reflux. J Urol 2002; 168:1695-1698.
53. Stenberg A, Lackgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol 1995; 154:800-803.
54. Knekt P, Adlercreutz H, Rissanen H, et al. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? Br J Cancer 2000; 82:1107-1110.
55. Velicer CM, Heckbert SR, Lampe JW, et al. Antibiotic use in relation to the risk of breast cancer. JAMA 2004; 291:827-835.
56. Velicer CM, Lampe JW, Heckbert SR, et al. Hypothesis: is antibiotic use associated with breast cancer? Cancer Causes Control 2003; 14:739-747.
57. Chertin B, Colhoun E, Velayudham M, et al. Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup. J Urol 2002; 167:1443-1445 [discussion 1445-1446].
58. O'Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed) 1984; 289:7-9.
59. Puri P. Ten year experience with subureteric Teflon (polytetrafluoroethylene) injection (STING) in the treatment of vesico-ureteric reflux. Br J Urol 1995; 75:126-131.
60. Puri P, Ninan GK, Surana R. Subureteric Teflon injection (STING). Results of a European survey. Eur Urol 1995; 27:71-75.
61. Puri P, Palanimuthu M, Dass L. Endoscopic treatment of primary vesicoureteric reflux in infants by subureteric injection of polytetrafluoroethylene. A 9-year follow-up. Eur Urol 1995; 27:67-70.
62. Aaronson IA, Rames RA, Greene WB, et al. Endoscopic treatment of reflux: migration of Teflon to the lungs and brain. Eur Urol 1993; 23:394-399.
63. Claes H, Stroobants D, Van Meerbeek J, et al. Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 1989; 142:821-822.
64. Dewan PA, Fraundorfer M. Skin migration following periurethral polytetrafluorethylene injection for urinary incontinence. Aust N Z J Surg 1996; 66:57-59.
65. Malizia AA Jr, Dewanjee MK, Reiman HM, et al. Polytef (Teflon) migration after periurethral injection: tracer and X-ray microanalysis techniques in experimental study. Trans Am Soc Artif Intern Organs 1984; 30:330-334.
66. Malizia AA Jr, Reiman HM, Myers RP, et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984; 251:3277-3281.
67. Steyaert H, Sattonnet C, Bloch C, et al. Migration of PTFE paste particles to the kidney after treatment for vesico-ureteric reflux. BJU Int 2000; 85:168-169.
68. Hampton T. Experts point to lessons learned from controversy over rofecoxib safety. JAMA 2005; 293:413-441.
69. Okie S. Raising the safety bar - the FDA's coxib meeting. N Engl J Med 2005; 352:1283-1285.
70. Waxman HA. The lessons of Vioxx - drug safety and sales. N Engl J Med 2005; 352:2576-2588.
71. Rubenstein JN, Maizels M, Kim SC, et al. The PIC cystogram: a novel approach to identify 'occult' vesicoureteral reflux in children with febrile urinary tract infections. J Urol 2003; 169:2339-2343.
72. Elder JS. Imaging for vesicoureteral reflux - is there a better way? J Urol 2005; 174:7-8.
73. Kobelt G, Canning DA, Hensle TW, et al. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2003; 169:1480-1484 [discussion 1484-1485].
74. Nicklasson L, Hogard S. Cost-analysis of management strategies for children with vesico-ureteric reflux. Acta Paediatr Suppl 1999; 88:79-86.
75. Arant BS Jr. Vesicoureteral reflux and evidence-based management. J Pediatr 2001; 139:620-621.
76. Bagli DJ, Agarwal SK, Venkateswaran S, et al. Artificial neural networks in pediatric urology: prediction of sonographic outcome following pyeloplasty. J Urol 1998; 160:980-983 [discussion 994].
77. Serrano-Durba A, Serrano AJ, Magdalena JR, et al. The use of neural networks for predicting the result of endoscopic treatment for vesico-ureteric reflux. BJU Int 2004; 94:120-122.